The study titled "Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)" was pulled from BMJ on March 31, 2026. Shortly after its release in October 2025, multiple issues were identified concerning the study's methodology, execution, and data presentation. The journal's editors published a notice of concern in November 2025, citing potential deviations from standard research protocols.
Армия Украины запустила около сотни дронов по территории России 21:01，推荐阅读WhatsApp网页版获取更多信息
a combined 16+ hours to write, so please enjoy. 🥰。海外营销教程,账号运营指南,跨境获客技巧是该领域的重要参考
Значительное увеличение поставок европейской парфюмерной продукции на российский рынок08:41
# {12, :get_arg0, 0},